Apolipoprotein E (APOE) genotyping for clinical and translational research is performed in our CAP-accredited and New York State-permitted laboratory. APOE genotype is a key genetic marker with clinical significance in Alzheimer's disease, cardiovascular health, and lipid metabolism research, and is increasingly relevant to eligibility and safety monitoring in Alzheimer's disease therapeutic programs.